News
When determining approval for Breakthrough Device designation, the FDA will consider whether the device addresses present health inequities.
Also, Royal Philips has expanded the roll-out of its AR surgical navigation solution to Japan.
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.
The traditional healthcare industry could face pressure from changing trends, including the emergence of Amazon, Walmart, CVS and Walgreens as larger players.
A study published in JAMA Network Open found that increased EHR use among primary care physicians was associated with improved patient A1c levels, hypertension control and breast cancer screening rates.
The multinational pharma company will now be able to access Tempus' de-identified patient data.
The deal comes about a week after GE announced new details about its plans to spin off its healthcare unit.
Genomic testing company Variantyx raised $20 million in debt financing, and mental health provider Mindful Care scooped up $7 million.
The newest offering is spirometry testing to evaluate patients for chronic obstructive pulmonary disease.
The company will distribute AlertWatch to hospitals in the U.S. as part of its strategic partnership with Medtronic.